Moreover, a significant positive correlation between Bmi-1 overexpression and tumor size, depth of invasion, or lymph node metastasis, and a significant negative correlation between Mel-18 low-expression with lymph node metastasis or the clinical stage were observed. The gene discussed is PCGF2; the disease is metastatic malignant neoplasm in the lymph nodes.